Maryland biologics regulations.

Who may administer PRP, exosomes and stem cells in Maryland, and which agencies to check.

A physician at a desk reading regulatory documents

Who may administer biologics in Maryland?

In Maryland, only licensed healthcare professionals may perform stem cell therapies. This includes medical doctors (MDs), osteopathic doctors (DOs), who have completed relevant training and certifications. Confirm qualifications and licensing requirements through the Maryland Board of Physicians at Maryland Board of Physicians.

Official sources

Maryland compliance guide.

FDA Compliance

The U.S. Food and Drug Administration (FDA) regulates human cells, tissues, and cellular and tissue-based products (HCT/P) under the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act. Clinics in Maryland must adhere to these guidelines to legally offer biologic therapies. Review the FDA's guidance on HCT/P products here and follow federal requirements to ensure compliance.

Maryland State Regulations

Maryland’s health department outlines specific regulations that apply to the provision of biologics and stem cell therapies within the state. Maryland providers should refer to the Maryland Department of Health for guidance on compliance, which can be accessed here. These state regulations support accessible compliance pathways and define permissible treatments within Maryland.

Provider Qualifications

In Maryland, only licensed healthcare professionals may perform stem cell therapies. This includes medical doctors (MDs), osteopathic doctors (DOs), who have completed relevant training and certifications. Confirm qualifications and licensing requirements through the Maryland Board of Physicians at Maryland Board of Physicians. These requirements ensure that providers meet essential safety and competency standards to administer biologics.

Patient Informed Consent

Maryland requires comprehensive informed consent for biologics, including stem cell treatments. Clinics must clearly outline the treatment's risks, benefits, alternatives, and any disclaimers, especially since some biologic therapies may be experimental. This consent must communicate that not all treatments are FDA-approved and that patients understand the nature of the therapy. Detailed guidance on Maryland’s informed consent protocols can be found through the Maryland Department of Health’s resources.

Additional Compliance Considerations

Pre-Treatment and Post-Treatment Protocols

Maryland clinics are encouraged to develop clear protocols for both pre-treatment screening and post-treatment care to ensure safety and compliance. These may include patient eligibility criteria, infection prevention, and follow-up schedules.

Standard Operating Procedures (SOPs)

Establish SOPs for handling biologics to comply with FDA and state guidelines. This includes procedures for product handling, storage, and administration to maintain compliance and patient safety.

Medical Liability Insurance

Providers in Maryland are advised to obtain medical liability insurance to cover biologic therapies. Check with insurers about specific policies that cover the risks associated with stem cell treatments.

Marketing Compliance

Maryland clinics must comply with advertising regulations that prohibit misleading claims. Avoid statements that imply FDA approval unless explicitly granted. Follow the Maryland Department of Health’s marketing guidelines, which help ensure ethical communication regarding biologics.

This guide is a general summary to help clinics understand compliance requirements for biologics in Maryland. It is not legal advice. Regulations change; consult legal counsel and the agencies above before acting on it.

Maryland: common questions.

Who can administer stem cells, PRP and exosomes in Maryland?
In Maryland, only licensed healthcare professionals may perform stem cell therapies. This includes medical doctors (MDs), osteopathic doctors (DOs), who have completed relevant training and certifications. Confirm qualifications and licensing requirements through the Maryland Board of Physicians at Maryland Board of Physicians. This is a general summary, not legal advice. Confirm with the state board.
Are stem cell and exosome therapies FDA-approved in Maryland?
FDA rules are federal, so they apply in Maryland as everywhere else. Exosome and stem cell therapies are not FDA-approved for therapeutic use, and PRP applications are considered off-label.
Do I need an IRB-approved study to offer biologics in Maryland?
Investigational treatment belongs inside a reviewed study with proper informed consent. IRB review is not FDA authorisation: culture-expanded and other more-than-minimally-manipulated cell products generally need an IND before use in people.
How do I start offering biologics in Maryland?
Start with the live webinar, then a discovery call and live training. After that we verify your Maryland licence, protocol, product sourcing, consent process and advertising before you are listed for patient inquiries.

Practising in Maryland? Start with the webinar.

Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.